Screener
IHE vs IWL
iShares U.S. Pharmaceuticals ETF vs iShares Russell Top 200 ETF
Key differences
- IWL costs 0.23% less per year.
- Over the last 3 years, IWL has delivered higher annualized returns.
Side-by-side comparison
| IHE | IWL | |
|---|---|---|
| Annual cost (TER) | 0.38% | 0.15% |
| Fund size (AUM) | $946M | $2.1B |
| Since | 2006 | 2009 |
| Dividend yield | 1.70% | 0.86% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +46.2% | +30.1% |
| CAGR 3Y | +18.0% | +24.4% |
| CAGR 5Y | +10.1% | +14.7% |
| Sharpe 3Y | 0.87 | 1.28 |
| Volatility 1Y | 16.91% | 12.34% |
| Max drawdown | -29.59% | -32.71% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IHE and IWL
Explore further